Long-term pain after knee surgery reduced, new treatment has shown
With one in five people experiencing ongoing pain long after knee replacement surgery, new research, led by the University of Bristol and North Bristol NHS Trust (NBT) and published in The Lancet Rheumatology today [27 January], has shown a way to help reduce people’s continuing pain that could also save the NHS time and money […]
What Is the Treatment for Common Variable Immunodeficiency?
Treatment for common variable immunodeficiency may include immunoglobulin replacement therapy, antimicrobial therapy, and B12 injections. The treatment of common variable immunodeficiency (CVID) is individualized depending upon various factors such as the person’s age, symptoms, and general health. Various specialists, including hematologists, pulmonologists, gastroenterologists, and immunologists, work as a team to decide the best management approach […]
TAVR Chugging Along at 5 Years in SURTAVI Trial
Researchers keeping an eye on the long-term outcomes of people undergoing transcatheter aortic valve replacement (TAVR) reported encouraging results in both clinical and economic terms, according to two reports from the Transcatheter Cardiovascular Therapeutics (TCT) meeting. The 5-year incidence of all-cause mortality or disabling stroke among people in the SURTAVI trial was no different between […]
New Enzyme Therapy OK’d for Pompe Disease
The FDA approved avalglucosidase alfa-ngpt (Nexviazyme) on Friday as a new enzyme replacement therapy for Pompe disease. Avalglucosidase alfa is an intravenous drug that targets the M6P receptor, and is indicated for late-onset disease for those ages 1 year and older. In patients with the disease, which is marked by dysfunction of the lysosomal enzyme […]